395 related articles for article (PubMed ID: 15123278)
1. Toxicogenomics in predictive toxicology in drug development.
Suter L; Babiss LE; Wheeldon EB
Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
[TBL] [Abstract][Full Text] [Related]
2. The state-of-the-art in predictive toxicogenomics.
Fielden MR; Kolaja KL
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
[TBL] [Abstract][Full Text] [Related]
3. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
[TBL] [Abstract][Full Text] [Related]
4. Toxicogenomics in the assessment of immunotoxicity.
Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
[TBL] [Abstract][Full Text] [Related]
5. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
Gatzidou ET; Zira AN; Theocharis SE
J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
[TBL] [Abstract][Full Text] [Related]
6. The Japanese toxicogenomics project: application of toxicogenomics.
Uehara T; Ono A; Maruyama T; Kato I; Yamada H; Ohno Y; Urushidani T
Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
Yang Y; Blomme EA; Waring JF
Chem Biol Interact; 2004 Nov; 150(1):71-85. PubMed ID: 15522262
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of toxicogenomics in the safety assessment of drug candidates.
Foster WR; Chen SJ; He A; Truong A; Bhaskaran V; Nelson DM; Dambach DM; Lehman-McKeeman LD; Car BD
Toxicol Pathol; 2007 Aug; 35(5):621-35. PubMed ID: 17654404
[TBL] [Abstract][Full Text] [Related]
9. State-of-the-art genomics approaches in toxicology.
Van Hummelen P; Sasaki J
Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
[TBL] [Abstract][Full Text] [Related]
10. Toxicogenomics in biomarker discovery.
Decristofaro MF; Daniels KK
Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
[TBL] [Abstract][Full Text] [Related]
11. The use of toxicogenomic data in risk assessment: a regulatory perspective.
Chan VS; Theilade MD
Clin Toxicol (Phila); 2005; 43(2):121-6. PubMed ID: 15822767
[TBL] [Abstract][Full Text] [Related]
12. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs.
Jacobs A
Toxicol Lett; 2009 Apr; 186(1):32-5. PubMed ID: 18809476
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy.
Burczynski ME
Toxicol Lett; 2009 Apr; 186(1):18-21. PubMed ID: 19022363
[TBL] [Abstract][Full Text] [Related]
14. Applications of toxicogenomics to nonclinical drug development: regulatory science considerations.
Sistare FD; Degeorge JJ
Methods Mol Biol; 2008; 460():239-61. PubMed ID: 18449491
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
16. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database.
Kondo C; Minowa Y; Uehara T; Okuno Y; Nakatsu N; Ono A; Maruyama T; Kato I; Yamate J; Yamada H; Ohno Y; Urushidani T
Toxicology; 2009 Nov; 265(1-2):15-26. PubMed ID: 19761811
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
[TBL] [Abstract][Full Text] [Related]
18. Application of toxicogenomics to genetic toxicology risk assessment.
Thybaud V; Le Fevre AC; Boitier E
Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
[TBL] [Abstract][Full Text] [Related]
19. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
[TBL] [Abstract][Full Text] [Related]
20. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
Merrick BA; Bruno ME
Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
